Literature DB >> 15451637

Dendrimers of citric acid and poly (ethylene glycol) as the new drug-delivery agents.

H Namazi1, M Adeli.   

Abstract

Citric acid-polyethylene glycol-citric acid (CPEGC) triblock dendrimers as biocompatible compounds containing G(1), G(2) and G(3) were applied as the drug-delivery systems. Some of the small size molecules and drugs are trapped with the above-synthesized dendrimers. The guest molecules, which are hydrophobic when trapped into the suitable sites of dendrimers, are becoming soluble in aqueous solution. The quantity of trapped molecules and drugs such as 5-amino salicylic acid (5-ASA), pyridine, mefenamic acid, and diclofenac was measured. The drug/dendrimer complexes remained in room temperature for about 10 months and after this long time they were stable and the drugs were not released. Also, the controlled release of the above-mentioned molecules and drugs in vitro conditions was investigated. The structure definition and controlled release of the molecules and drugs were carried out using different spectroscopy methods.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15451637     DOI: 10.1016/j.biomaterials.2004.04.014

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  31 in total

Review 1.  Synthetic Biomaterials from Metabolically Derived Synthons.

Authors:  Nicole G Ricapito; Cynthia Ghobril; Heng Zhang; Mark W Grinstaff; David Putnam
Journal:  Chem Rev       Date:  2016-01-29       Impact factor: 60.622

2.  Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers.

Authors:  Hannah L Crampton; Eric E Simanek
Journal:  Polym Int       Date:  2007-03-02       Impact factor: 2.990

3.  Reduction toxicity of Amphotericin B through loading into a novel nanoformulation of anionic linear globular dendrimer for improve treatment of leishmania major.

Authors:  Tahereh Zadeh Mehrizi; Mehdi Shafiee Ardestani; Ali Khamesipour; Mostafa Haji Molla Hoseini; Nariman Mosaffa; Ali Anissian; Amitis Ramezani
Journal:  J Mater Sci Mater Med       Date:  2018-07-28       Impact factor: 3.896

4.  Evaluation of poly(amidoamine) dendrimers as potential carriers of iminodiacetic derivatives using solubility studies and 2D-NOESY NMR spectroscopy.

Authors:  Magdalena Markowicz; Paweł Szymański; Marcin Ciszewski; Arkadiusz Kłys; Elżbieta Mikiciuk-Olasik
Journal:  J Biol Phys       Date:  2012-08-16       Impact factor: 1.365

5.  Novel PH Sensitive Nanocarrier Agents Based on Citric Acid Dendrimers Containing Conjugated β-Cyclodextrins.

Authors:  Hassan Namazi; Yousef Toomari Hamrahloo
Journal:  Adv Pharm Bull       Date:  2011-07-20

6.  Anionic linear-globular dendrimers: biocompatible hybrid materials with potential uses in nanomedicine.

Authors:  Mohammad Shafiee Alavidjeh; Ismaeil Haririan; Mohammad Reza Khorramizadeh; Zohre Zarei Ghane; Mehdi Shafiee Ardestani; Hassan Namazi
Journal:  J Mater Sci Mater Med       Date:  2010-01-16       Impact factor: 3.896

7.  Anionic linear-globular dendrimer-cis-platinum (II) conjugates promote cytotoxicity in vitro against different cancer cell lines.

Authors:  Ismaeil Haririan; Mohammad Shafiee Alavidjeh; Mohammad Reza Khorramizadeh; Mehdi Shafiee Ardestani; Zohre Zarei Ghane; Hassan Namazi
Journal:  Int J Nanomedicine       Date:  2010-02-02

8.  Synthesis of New Functionalized Citric Acid-based Dendrimers as Nanocarrier Agents for Drug Delivery.

Authors:  Hassan Namazi; Sanaz Motamedi; Mina Namvari
Journal:  Bioimpacts       Date:  2011-06-09

Review 9.  The baffling human body and the boundless nanomaterial boon-a trap for cancer crab.

Authors:  S Jeelani; G S Asokan; G Anuradha; J Parthiban; T Sivasankari
Journal:  J Clin Diagn Res       Date:  2014-07-20

10.  A biodegradable thermoset polymer made by esterification of citric acid and glycerol.

Authors:  Jeffrey M Halpern; Richard Urbanski; Allison K Weinstock; David F Iwig; Robert T Mathers; Horst A von Recum
Journal:  J Biomed Mater Res A       Date:  2013-06-24       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.